RxDoctor Payments Data

Madelyn Eudy, PA

Physician Assistant · Charlotte, NCNPI 1578103636

Payments from drug & device makers

$10,906in general payments, 2019–2025

Across 638 payments — averaging $17.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$741
  • Lilly USA, LLC$551
  • AstraZeneca$494
  • Bausch Health US, LLC$485
  • Johnson & Johnson$451
  • plus $6K from 54 others

What the payments were for

  • Food & beverage$10,72098%
  • Education$1852%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)123$1,848
Novo Nordisk48$741
Lilly USA, LLC33$551
AstraZeneca18$494
Bausch Health US, LLC48$485
Johnson & Johnson(2 entities)20$451
Biohaven Pharmaceutical Holding Company Ltd.20$343
Amgen(2 entities)21$341
Pfizer21$314
Bayer17$309
Boehringer Ingelheim15$295
Biohaven Pharmaceuticals, Inc.14$286
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC13$273
Merck16$269
Novartis12$253
Takeda Pharmaceuticals U.S.A., Inc.15$245
Eisai Inc.11$221
Sanofi9$212
Regeneron Healthcare Solutions, Inc.13$209
Antares Pharma, Inc.9$204
Esperion Therapeutics, Inc.6$199
Amarin Pharma, Inc.9$168
Clarus Therapeutics Inc.9$158
Sumitomo Pharma America, Inc.6$151
Theratechnologies Inc.6$143
GSK7$135
Arbor Pharmaceuticals, Inc.8$132
Exact Sciences6$118
Neos Therapeutics, LP7$117
Sanofi-aventis U.S. LLC5$98
Paratek Pharmaceuticals, Inc.5$81
Aytu Biopharma, Inc.6$71
Tolmar, Inc.4$67
Avanir Pharmaceuticals, Inc.4$63
Kowa Pharmaceuticals America, Inc.4$58
Supernus Pharmaceuticals, Inc.4$58
Astellas Pharma US Inc2$53
GRT US Holding, Inc.3$51
Amneal Pharmaceuticals LLC3$51
Xeris Pharmaceuticals, Inc.2$39
Sunovion Pharmaceuticals Inc.2$37
Azurity Pharmaceuticals, Inc.2$36
Idorsia Pharmaceuticals US Inc2$35
Shield Therapeutics Inc2$34
Noven Therapeutics, LLC2$29
E.r. Squibb & Sons, L.L.C.2$28
Incyte Corporation1$28
Currax Pharmaceuticals LLC2$27
Ironwood Pharmaceuticals, Inc1$27
Almirall LLC1$21
Gilead1$21
Hikma Pharmaceuticals USA1$20
Corcept Therapeutics1$20
Organon4$20
Boston Scientific1$19
Dexcom, Inc.1$18
Optinose US, Inc.1$18
Genentech USA, Inc.2$17
Galderma Laboratories, L.p.1$17
Almatica Pharma LLC1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,906 in reported general payments places this provider in the 95th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$20,484
Medicare patients
132
Services billed
335

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide13$13,884
Atorvastatin Calcium30$399
Metoprolol Succinate11$289
Ketoconazole15$269
Levothyroxine Sodium16$244
Zolpidem Tartrate18$154
Gabapentin14$132
Amlodipine Besylate16$124
Rosuvastatin Calcium12$117
Triamcinolone Acetonide15$105
Metformin Hcl17$79
Alprazolam17$46

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$741$13,88413 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$51$24416 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Charlotte

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →